| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/12/2023 | 10.54% | UBS | $82 → $80 | Maintains | Neutral |
| 07/24/2023 | 21.6% | BMO Capital | $90 → $88 | Maintains | Market Perform |
| 07/24/2023 | 9.16% | Goldman Sachs | $69 → $79 | Maintains | Sell |
| 07/21/2023 | 9.16% | Goldman Sachs | $69 → $79 | Maintains | Sell |
| 07/21/2023 | 31.27% | Baird | $97 → $95 | Maintains | Outperform |
| 07/05/2023 | 13.31% | UBS | $77 → $82 | Maintains | Neutral |
| 06/20/2023 | 29.89% | Redburn Partners | → $94 | Initiates Coverage On | → Buy |
| 06/01/2023 | 6.4% | UBS | → $77 | Initiates Coverage On | → Neutral |
| 04/27/2023 | — | Argus Research | Downgrades | Buy → Hold | |
| 04/24/2023 | 10.54% | BMO Capital | $92 → $80 | Maintains | Market Perform |
| 04/21/2023 | 10.54% | Truist Securities | $92 → $80 | Maintains | Hold |
| 04/21/2023 | 34.03% | Baird | $101 → $97 | Maintains | Outperform |
| 02/01/2023 | 27.12% | Truist Securities | $80 → $92 | Maintains | Hold |
| 02/01/2023 | 39.56% | Baird | $94 → $101 | Maintains | Outperform |
| 01/26/2023 | — | Northcoast Research | Downgrades | Buy → Neutral | |
| 12/05/2022 | 0.87% | Goldman Sachs | $64 → $73 | Maintains | Sell |
| 10/25/2022 | -0.51% | Jefferies | → $72 | Assumes | → Hold |
| 10/10/2022 | -3.27% | Barclays | $80 → $70 | Maintains | Underweight |
| 07/22/2022 | 10.54% | Barclays | $100 → $80 | Maintains | Underweight |
| 07/15/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 07/11/2022 | 7.78% | JP Morgan | → $78 | Downgrades | Overweight → Neutral |
| 05/26/2022 | 16.07% | BMO Capital | $120 → $84 | Downgrades | Outperform → Market Perform |
| 04/20/2022 | 45.09% | Credit Suisse | $115 → $105 | Maintains | Neutral |
| 04/20/2022 | 65.81% | BMO Capital | $116 → $120 | Maintains | Outperform |
| 04/14/2022 | 60.29% | BMO Capital | $133 → $116 | Maintains | Outperform |
| 10/20/2021 | 78.25% | BMO Capital | $139 → $129 | Maintains | Outperform |
| 09/17/2021 | 65.81% | Barclays | $140 → $120 | Downgrades | Overweight → Underweight |
| 08/25/2021 | 93.45% | Truist Securities | $130 → $140 | Maintains | Buy |
| 07/21/2021 | 58.91% | Credit Suisse | $110 → $115 | Maintains | Neutral |
| 04/26/2021 | 93.45% | Barclays | $120 → $140 | Maintains | Overweight |
| 04/21/2021 | 97.6% | Baird | $135 → $143 | Maintains | Outperform |
| 03/01/2021 | 65.81% | Barclays | $70 → $120 | Upgrades | Underweight → Overweight |
| 02/03/2021 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 12/21/2020 | — | Northcoast Research | Upgrades | Neutral → Buy | |
| 11/23/2020 | 38.18% | BMO Capital | → $100 | Upgrades | Market Perform → Outperform |
| 10/21/2020 | 21.6% | JP Morgan | $76 → $88 | Upgrades | Neutral → Overweight |
| 09/21/2020 | 24.36% | Truist Securities | $64 → $90 | Upgrades | Hold → Buy |
| 07/21/2020 | 17.45% | Baird | $70 → $85 | Maintains | Outperform |
| 07/14/2020 | -25.38% | Goldman Sachs | $57 → $54 | Downgrades | Neutral → Sell |
| 05/21/2020 | -3.27% | Credit Suisse | → $70 | Upgrades | Underperform → Neutral |
| 04/22/2020 | 24.36% | RBC Capital | $86 → $90 | Maintains | Outperform |
| 04/20/2020 | -3.27% | BMO Capital | $67 → $70 | Maintains | Market Perform |
| 03/19/2020 | 0.87% | Baird | $101 → $73 | Maintains | Outperform |
| 03/19/2020 | -6.04% | Barclays | $112 → $68 | Downgrades | Overweight → Underweight |
| 01/14/2020 | 54.76% | Barclays | → $112 | Upgrades | Equal-Weight → Overweight |
| 11/22/2019 | 32.65% | Jefferies | → $96 | Initiates Coverage On | → Hold |
| 11/13/2019 | — | CL King | Initiates Coverage On | → Buy | |
| 10/30/2019 | — | Argus Research | Downgrades | Buy → Hold | |
| 10/21/2019 | 21.6% | BMO Capital | $86 → $88 | Maintains | Market Perform |
| 09/26/2019 | 24.36% | SunTrust Robinson Humphrey | $97 → $90 | Maintains | Hold |
| 07/22/2019 | 32.65% | B of A Securities | $100 → $96 | Maintains | Neutral |
| 07/22/2019 | 36.8% | JP Morgan | $96 → $99 | Maintains | Neutral |
| 07/22/2019 | 52% | RBC Capital | $114 → $110 | Maintains | Outperform |
| 07/11/2019 | 14.69% | Credit Suisse | $88 → $83 | Downgrades | Neutral → Underperform |
| 06/12/2019 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
| 04/17/2019 | — | RBC Capital | Initiates Coverage On | → Outperform | |
| 02/01/2019 | — | BMO Capital | Downgrades | Outperform → Market Perform | |
| 10/22/2018 | 17.45% | BMO Capital | $90 → $85 | Maintains | Outperform |
| 10/22/2018 | 34.03% | Baird | $101 → $97 | Maintains | Outperform |
| 10/22/2018 | 31.27% | Argus Research | $135 → $95 | Maintains | Buy |
| 10/22/2018 | 13.31% | JP Morgan | $120 → $82 | Downgrades | Overweight → Neutral |
What is the target price for ManpowerGroup (MAN)?
The latest price target for ManpowerGroup (NYSE: MAN) was reported by UBS on October 12, 2023. The analyst firm set a price target for $80.00 expecting MAN to rise to within 12 months (a possible 10.54% upside). 17 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for ManpowerGroup (MAN)?
The latest analyst rating for ManpowerGroup (NYSE: MAN) was provided by UBS, and ManpowerGroup maintained their neutral rating.
When is the next analyst rating going to be posted or updated for ManpowerGroup (MAN)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ManpowerGroup, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ManpowerGroup was filed on October 12, 2023 so you should expect the next rating to be made available sometime around October 12, 2024.
Is the Analyst Rating ManpowerGroup (MAN) correct?
While ratings are subjective and will change, the latest ManpowerGroup (MAN) rating was a maintained with a price target of $82.00 to $80.00. The current price ManpowerGroup (MAN) is trading at is $72.37, which is out of the analyst's predicted range.